Skip to main content
Top
Published in: Infection 6/2020

01-12-2020 | Human Immunodeficiency Virus | Brief Report

Detection of HIV-1 viral load in tears of HIV/AIDS patients

Authors: Yujing Qian, Zunyou Wu, Chao Chen, Kuifang Du, Wenbin Wei

Published in: Infection | Issue 6/2020

Login to get access

Abstract

Objectives

The tear, as an important bodily secretion, plays a crucial role in preventing infection and maintaining homeostasis of ocular surfaces. Although accumulating studies have reported on the HIV-1 viral load profile among varying bodily fluids and secretions, little was known concerning HIV-1 dynamics in tears. Therefore, the objectives of this study were to investigate the HIV-1 viral load in tears of HIV/AIDS patients and study factors influencing their tear viral load.

Methods

A cross-sectional study was conducted. 67 patients with a confirmed HIV-1 infection or AIDS were recruited from the Beijing You’an Hospital, China between April 2018 and September 2018. Socio-demographic information and laboratory test results were collected. At the same time, ophthalmic examinations were carried out and tear samples were tested.

Results

Of 30 highly active antiretroviral therapy (HAART)-naïve patients, 53.3% had detectable HIV-1 RNA in tears. Of 37 patients on HAART, HIV-1 RNA was undetectable in their tears, regardless of treatment duration and blood viral load. Tear viral load ranged from TND (target not detected) to 13,096 copies/mL. Viral load was lower in tears than in blood plasma (p < 0.001), and was significantly correlated with plasma viral load (Rho = 0.566, p < 0.001) and AIDS stage (Rho = 0.312, p = 0.01), but negatively correlated with CD4 + T cell count, CD4 +/CD8 + T cell count, and duration of HIV infection (Rho = -0.450, Rho = − 0.464, Rho = − 0.565; p < 0.001).

Conclusions

HIV-1 RNA is present in tears of more than half of the HAART-naïve patients, whereas absent in tears of patients on HAART. Tear viral load is positively associated with plasma viral load while it is negatively correlated with CD4 cell count. This study provides novel insights into the area with limited understanding–HIV-1 viral load in tears.
Literature
1.
go back to reference Shepard RN, Schock J, Robertson K, Shugars DC, Dyer J, Vernazza P, Hall C, Cohen MS, Fiscus SA. Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments. J Clin Microbiol. 2000;38:1414–8.CrossRef Shepard RN, Schock J, Robertson K, Shugars DC, Dyer J, Vernazza P, Hall C, Cohen MS, Fiscus SA. Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments. J Clin Microbiol. 2000;38:1414–8.CrossRef
2.
go back to reference Anderson AM, Muñoz-Moreno JA, McClernon DR, et al. Prevalence and correlates of persistent HIV-1 RNA in cerebrospinal fluid during antiretroviral therapy. J Infect Dis. 2017;215:105–13.CrossRef Anderson AM, Muñoz-Moreno JA, McClernon DR, et al. Prevalence and correlates of persistent HIV-1 RNA in cerebrospinal fluid during antiretroviral therapy. J Infect Dis. 2017;215:105–13.CrossRef
3.
go back to reference Pilcher CD, Shugars DC, Fiscus SA, Miller WC, Menezes P, Giner J, Dean B, Robertson K, Hart CE, Lennox JL, Eron JJ Jr, Hicks CB. HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS. 2001;15:837–45.CrossRef Pilcher CD, Shugars DC, Fiscus SA, Miller WC, Menezes P, Giner J, Dean B, Robertson K, Hart CE, Lennox JL, Eron JJ Jr, Hicks CB. HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS. 2001;15:837–45.CrossRef
4.
go back to reference Di Zazzo A, Micera A, De Piano M, Cortes M, Bonini S. Tears and ocular surface disorders: usefulness of biomarkers. J Cell Physiol. 2019;234:9982–93.CrossRef Di Zazzo A, Micera A, De Piano M, Cortes M, Bonini S. Tears and ocular surface disorders: usefulness of biomarkers. J Cell Physiol. 2019;234:9982–93.CrossRef
5.
go back to reference Fujikawa LS, Salahuddin SZ, Palestine AG, Masur H, Nussen-blatt RB, Gallo RC. Isolation of human T-lymphotropic virus type III from the tears of a patient with the acquired immunodeficiency syndrome. Lancet. 1985;2:529–30.CrossRef Fujikawa LS, Salahuddin SZ, Palestine AG, Masur H, Nussen-blatt RB, Gallo RC. Isolation of human T-lymphotropic virus type III from the tears of a patient with the acquired immunodeficiency syndrome. Lancet. 1985;2:529–30.CrossRef
6.
go back to reference Mueller AJ, Klauss V, Gürtler L, Geier S. Infrequent detection of HIV-1 components in tears compared to blood of HIV-1-infected persons. Infection. 1992;20:249–52.CrossRef Mueller AJ, Klauss V, Gürtler L, Geier S. Infrequent detection of HIV-1 components in tears compared to blood of HIV-1-infected persons. Infection. 1992;20:249–52.CrossRef
7.
go back to reference Han Y, Wu N, Zhu W, Li Y, Zuo L, Ye J, et al. Detection of HIV-1 viruses in tears of patients even under long-term HAART [Letter]. AIDS. 2011;25:1925–7.CrossRef Han Y, Wu N, Zhu W, Li Y, Zuo L, Ye J, et al. Detection of HIV-1 viruses in tears of patients even under long-term HAART [Letter]. AIDS. 2011;25:1925–7.CrossRef
8.
go back to reference Fiore JR, Suligoi B, Saracino A, Di Stefano M, Bugarini R, Lepera A, et al. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies. AIDS. 2003;17:2169–76.CrossRef Fiore JR, Suligoi B, Saracino A, Di Stefano M, Bugarini R, Lepera A, et al. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies. AIDS. 2003;17:2169–76.CrossRef
9.
go back to reference Kantor R, Bettendorf D, Bosch RJ, Mann M, Katzenstein D, Cu-Uvin S, et al. HIV-1 RNA Levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077. PLoS ONE. 2014;9:e93537.CrossRef Kantor R, Bettendorf D, Bosch RJ, Mann M, Katzenstein D, Cu-Uvin S, et al. HIV-1 RNA Levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077. PLoS ONE. 2014;9:e93537.CrossRef
10.
go back to reference Cao W, Hsieh E, Li T. Optimizing treatment for adults with HIV/AIDS in China: successes over two decades and remaining challenges. Curr HIV/AIDS Rep. 2020;17:26–34.CrossRef Cao W, Hsieh E, Li T. Optimizing treatment for adults with HIV/AIDS in China: successes over two decades and remaining challenges. Curr HIV/AIDS Rep. 2020;17:26–34.CrossRef
11.
go back to reference Mujugira A, Coombs RW, Heffron R, Celum C, Ronald A, Mugo N, et al. Seminal HIV-1 RNA detection in heterosexual African men initiating antiretroviral therapy. J Infect Dis. 2016;214:212–5.CrossRef Mujugira A, Coombs RW, Heffron R, Celum C, Ronald A, Mugo N, et al. Seminal HIV-1 RNA detection in heterosexual African men initiating antiretroviral therapy. J Infect Dis. 2016;214:212–5.CrossRef
12.
go back to reference Soulie C, Grudé M, Descamps D, Amiel C, Morand-Joubert L, Raymond S, et al. Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma. J Antimicrob Chemother. 2017;72:2351–4.PubMed Soulie C, Grudé M, Descamps D, Amiel C, Morand-Joubert L, Raymond S, et al. Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma. J Antimicrob Chemother. 2017;72:2351–4.PubMed
Metadata
Title
Detection of HIV-1 viral load in tears of HIV/AIDS patients
Authors
Yujing Qian
Zunyou Wu
Chao Chen
Kuifang Du
Wenbin Wei
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 6/2020
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-020-01508-2

Other articles of this Issue 6/2020

Infection 6/2020 Go to the issue